Login / Signup

Does Timing of Antihypertensive Medication Dosing Matter?

Ramón C HermidaRamón G Hermida-AyalaMichael H SmolenskyArtemio MojónJuan J CrespoAlfonso OteroMaría T RíosManuel Domínguez-SardiñaJosé R Fernández
Published in: Current cardiology reports (2020)
The vast (81.6%) majority of the 136 published short-term treatment-time trials document benefits, including enhanced reduction of asleep BP and increased sleep-time relative BP decline (dipping), when hypertension medications and their combinations are ingested before sleep rather than upon waking. Long-term outcome trials further document bedtime hypertension therapy markedly reduces risk of major CVD events. The inability of the very small 18.4% of the published trials to substantiate treatment-time difference in effects is mostly explained by deficiencies of study design and conduct. Our comprehensive review of the published literature reveals no single study has reported better benefits of the still conventional, yet scientifically unjustified, morning than bedtime hypertension treatment scheme.
Keyphrases
  • blood pressure
  • healthcare
  • physical activity
  • stem cells
  • emergency department
  • randomized controlled trial
  • mesenchymal stem cells
  • combination therapy
  • bone marrow
  • electronic health record
  • arterial hypertension